I see they update item #15. I had texted Joe that it was incorrect in the proxy we voted on already. It said 20:1 shares of NGIO instead of 1:4. I would have been VERY HAPPY if the 20:1 was correct.

Quote:

---

Item 15. Acquisition or Disposition of Property.




Generex had issued a dividend of Antigen Express, Inc. d/b/a NuGenerex Immuno-Oncology to its shareholders in the amount of 1 share of Antigen Express, Inc. for every 4 shares of Generex common stock in February 2019. While this is not a disposition of one of its subsidiaries as Generex maintains majority control, it should be noted for full disclosure that Generex diluted its interest in Antigen to the benefit of Generex’s shareholders.

---